Oruka Therapeutics (ORKA) Other Non-Current Assets (2010 - 2026)

Oruka Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $103000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $103000.0; the TTM figure through Mar 2026 stood at $103000.0 (changed 0.0% YoY), while the FY2025 annual figure was $103000.0, up 139.53% from the prior year.
• Other Non-Current Assets was $103000.0 for Q1 2026 at Oruka Therapeutics, roughly flat from $103000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $103000.0 in Q1 2025 to a low of $12000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $44529.4 across 5 years, with a median of $18000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets sank 33.33% in 2023, then jumped 758.33% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $18000.0 in 2022, then sank by 33.33% to $12000.0 in 2023, then surged by 258.33% to $43000.0 in 2024, then soared by 139.53% to $103000.0 in 2025, then changed by 0.0% to $103000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $103000.0 (Q1 2026), $103000.0 (Q4 2025), and $103000.0 (Q3 2025), per Business Quant data.